CAS
VRCA icon

Coppell Advisory Solutions’s Verrica Pharmaceuticals VRCA Stock Holding History

Coppell Advisory Solutions’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$140 – 1832
2024
Q4 		$140 Hold
20
– – ﹤0.01% 1867
2024
Q3 		$338 Hold
20
– – ﹤0.01% 1694
2024
Q2 		$1.46K Buy
+20
New +$1.54K ﹤0.01% 1440
2023
Q4 		$1.46K Hold
20
– – ﹤0.01% 1353
2023
Q3 		$550 Hold
20
– – ﹤0.01% 1002
2023
Q2 		$1.15K Buy
+20
New +$1.21K ﹤0.01% 1118
2023
Q1 		– Sell
-20
Closed -$550 – 1066
2022
Q4 		$550 Buy
+20
New +$534 ﹤0.01% 1008

Other funds holding VRCA

CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return